Want to see TSE:GCR full AI Analyst Report?
Psyence Group (GCR) AI Stock Analysis
Top Page
Psyence Group
(CNQX:GCR)
No summary available
Psyence Group (GCR) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 4.72M
- Dividend Yield
- ―
- Average Volume (3M)
- 39.74K
- Price to Earnings (P/E)
- -0.5
- Beta (1Y)
- 0.05
- Revenue Growth
- ―
- EPS Growth
- 97.23%
- Country
- Canada
- Employees
- 5
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Gold
Psyence Group Business Overview & Revenue Model
Company Description
GoldCoast Resource Corp. engages in the exploration of gold deposits in Ghana. The company is based in Toronto, Canada.
How the Company Makes Money
null
Psyence Group Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GCR, the sentiment is Negative. The current price of 0.47 is below the 20-day moving average (MA) of 0.56, below the 50-day MA of 0.71, and below the 200-day MA of 0.80, indicating a bearish trend. The MACD of -0.07 indicates Negative momentum. The RSI at 32.97 is Neutral, neither overbought nor oversold. The STOCH value of 28.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GCR.
Psyence Group Peers Comparison
Overall Rating
TSE:RVV45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:RVV | 45Neutral | CAD 8.37M | -0.83 | 288.66% | ― | ― | 90.84% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:GCR | Psyence Group Inc. | 0.47 | -0.36 | -43.65% | |
| TSE:RVV | Revive Therapeutics | 0.02 | 0.01 | 100.00% | |
| TSE:MYND | Mynd Life Sciences Inc | 0.07 | 0.00 | 0.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.